Comparable Survival for Hepatitis C–Related Hepatocellular Carcinoma After Liver Transplantation Irrespective of Viremic Status

Direct-acting antiviral (DAA) therapy for the treatment of chronic hepatitis C virus (HCV) infection is efficacious and well-tolerated in the post-liver transplant (LT) setting, prompting increased use of donors with HCV infection in patients waitlisted for LT.1,2 Although the incidence of nonviral...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical gastroenterology and hepatology 2023-05, Vol.21 (5), p.1362-1364.e1
Hauptverfasser:	Lymberopoulos, Peter, Shaikh, Anjiya, Rich, Nicole E., Benhammou, Jihane N., Kanwal, Fasiha, Cholankeril, George
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antiviral Agents - therapeutic use Carcinoma, Hepatocellular - drug therapy Carcinoma, Hepatocellular - epidemiology Hepacivirus - genetics Hepatitis C - drug therapy Hepatitis C, Chronic - complications Hepatitis C, Chronic - drug therapy Humans Liver Neoplasms - drug therapy Liver Neoplasms - epidemiology Liver Transplantation United States Viremia - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!